Using mild oxygen deprivation to improve sleep apnea treatment
Mild intermittent hypoxia and CPAP: A multi-pronged approach to treat sleep apnea in intact and spinal cord injured humans
This study is looking at how a gentle form of low oxygen can help make CPAP therapy for sleep apnea work better by strengthening the muscles in your throat, and it also hopes to find out if this approach can improve heart health and overall well-being for people with sleep apnea.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wayne State University NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project ID | NIH-10445039 on NIH RePORTER |
What this research studies
This research investigates how mild intermittent hypoxia (IH) can enhance the effectiveness of continuous positive airway pressure (CPAP) therapy for sleep apnea. By exposing patients to mild IH, the study aims to increase muscle activity in the upper airway, which may lead to better airway stability and improved compliance with CPAP treatment. The research also explores the potential cardiovascular and metabolic benefits of this approach, which could help reduce health issues associated with sleep apnea. Patients will be monitored for changes in autonomic and cardiovascular functions as part of the study.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with obstructive sleep apnea who are currently using or are candidates for CPAP therapy.
Not a fit: Patients who do not have sleep apnea or those who are unable to tolerate CPAP therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for sleep apnea, enhancing patient compliance and reducing related health complications.
How similar studies have performed: Previous studies have shown promising results with mild intermittent hypoxia as a therapeutic approach, indicating potential for success in this novel application.
Where this research is happening
Detroit, United States
- Wayne State University — Detroit, United States (Active)
Researchers
- Principal investigator: Mateika, Jason H. — Wayne State University
- Study coordinator: Mateika, Jason H.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.